Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges

Journal of Medicinal Chemistry

Volumn 41, Issue 14, 1998, Pages 2614-2620

  Rivier, Jean ^a   Lahrichi, Sabine L ^a   Gulyas, Jozsef ^a   Erchegyi, Judit ^a,b   Koerber, Steven C ^a   Craig, A Grey ^a   Corrigan, Anne ^a   Rivier, Catherine ^a   Vale, Wylie ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[8-41]; CORTICOTROPIN RELEASING FACTOR[8-41] DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CYCLIZATION; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; ELECTROPHORESIS, CAPILLARY; GLUTAMINE; HUMANS; LYSINE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PITUITARY GLAND, ANTERIOR; RATS; RATS, SPRAGUE-DAWLEY; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032474856     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980164e     Document Type: Article

References (35)

1. Miranda, A.; Koerber, S. C.; Gulyas, J.; Lahrichi, S.; Craig, A. G.; Corrigan, A.; Hagler, A.; Rivier, C.; Vale, W.; Rivier, J. Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor. J. Med. Chem. 1994, 37, 1450-1459.
2. Gulyas, J.; Rivier, C.; Perrin, M.; Koerber, S. C.; Button, S.; Corrigan, A.; Lahrichi, S. L.; Craig, A. G.; Vale, W.; Rivier, J. Potent, structurally constrained agonists and competitive antagonists of corticotropin releasing factor (CRF). Proc. Natl. Acad. Sci. U.S.A. 1990, 92, 10575-10579.
3. Miranda, A.; Lahrichi, S. L.; Gulyas, J.; Koerber, S. C.; Craig, A. G.; Corrigan, A.; Rivier, C.; Vale, W.; Rivier, J. Constrained Corticotropin-Releasing Factor (CRF) Antagonists with i-(i+3) Glu-Lys bridges. J. Med. Chem. 1997, 40, 3651-3658.
4. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin. Science 1981, 213, 1394-1397.
5. Rivier, C. L.; Plotsky, P. M. Mediation by corticotropin-releasing factor (CRF) of adenohypophysial hormone secretion. Annu. Rev. Physiol. 1986, 48, 475-494.
6. Munck, A.; Guyre, P. M. Glucocorticoid physiology, pharmacology and stress. Adv. Exp. Med. Biol. 1986, 196, 81-96.
7. Dallman, M. F.; Strack, A. M.; Akana, S. F.; Bradbury, M. J.; Hanson, E. S.; Scribner, K. A.; Smith, M. Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol. 1993, 14, 303-347.
8. Corticotropin-Releasing Factor; Ciba Foundation Symposium 172; Vale, W., Ed.; John Wiley & Sons: West Sussex, England, 1993; p 357.
9. Chen, R.; Lewis, K. A.; Perrin, M. H.; Vale, W. W. Expression cloning of a human corticotropin releasing factor (CRF) receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8967-8971.
10. Chang, C. P.; Pearse, R. V., II; O'Connell, S.; Rosenfeld, M. G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993, 11, 1187-1195.
11. Perrin, M.; Donaldson, C.; Chen, R.; Blount, A.; Berggren, T.; Bilezikjian, L.; Sawchenko, P.; Vale, W. Identification of a second CRF receptor gene and characterization of a cDNA expressed in heart. Proc. Natl Acad. Sci. U.S.A. 1995, 92, 2969-2973.
12. Kishimoto, T.; Pearse, R. V., II; Lin, C. R.; Rosenfeld, M. G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 1108-1112.
13. Vita, N.; Laurent, P.; Lefort, S.; Chalon, P.; Lelias, J. M.; Kaghad, M.; Le, F. G.; Caput, D.; Ferrara, P. Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptors. FEBS Lett. 1993, 335, 1-6.
14. Lovenberg, T. W.; Liaw, C. W.; Grigoriadis, D. E.; Clevenger, W.; Chalmers, D. T.; DeSouza, E. B.; Oltersdorf, T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 836-840.
15. Perrin, M. H.; Donaldson, C. J.; Chen, R.; Lewis, K. A.; Vale, W. W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133, 3058-3061.
16. Potter, E.; Behan, D. P.; Fischer, W. H.; Linton, E. A.; Lowry, P. J.; Vale, W. W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 1991, 349, 423-426.
17. Pallai, P. V.; Mabilia, M.; Goodman, M.; Vale, W.; Rivier, J. Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: Circular dichroism and prediction studies. Proc. Natl Acad. Sci. U.S.A. 1983, 80, 6770-6774.
18. Rivier, J.; Rivier, C.; Galyean, R.; Miranda, A.; Miller, C.; Craig, A. G.; Yamamoto, G.; Brown, M.; Vale, W. Single point D-substituted corticotropin releasing factor analogues: Effects on potency and physicochemical characteristics. J. Med. Chem. 1993, 36, 2851-2859.
19. Felix, A. M.; Heimer, E. P.; Wang, C. T.; Lambros, T. J.; Fournier, A.; Mowles, T. F.; Maines, S.; Campbell, R. M.; Wegrzynski, B. B.; Toome, V.; Fry, D.; Madison, V. S. Synthesis, biological activity and conformational analysis of cyclic GRF analogues. Int. J. Pept. Protein Res. 1988, 32, 441-454.
20. Hoeger, C.; Galyean, R.; Boublik, J.; McClintock, R.; Rivier, J. Preparative reversed phase high performance liquid chromatography. II. Effects of buffer pH on the purification of synthetic peptides. Biochromatography 1987, 2, 134-142.
21. Rivier, J. Use of trialkylammonium phosphate (TAAP) buffers in reverse phase HPLC for high resolution and high recovery of peptides and proteins. J. Liq. Chromatogr. 1978, 1, 343-367.
22. Rivier, J.; Rivier, C.; Vale, W. Synthetic competitive antagonists of corticotropin releasing factor: Effect on ACTH secretion in the rat. Science 1984, 224, 889-891.
23. Vale, W.; Vaughan, J.; Yamamoto, G.; Bruhn, T.; Douglas, C.; Dalton, D.; Rivier, C.; Rivier, J. Assay of corticotropin releasing factor. In Methods in Enzymology: Neuroendocrine Peptides; Conn, P. M., Ed.; Academic Press: New York, 1983; Vol. 103, pp 565-577.
24. Rivier, J.; Spiess, J.; Vale, W. Characterization of rat hypothalamic corticotropin-releasing factor. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 4851-4855.
25. Martinez, J.; Bali, J.-P.; Rodriguez, M.; Castro, B.; Magous, R.; Laur, J.; Ligon, M.-F. Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: the importance of the peptide backbone. J. Med. Chem. 1985, 28, 1874-1879.0
26. Llinares, M.; Devin, C.; Azay, J.; Bergé, G.; Fehrentz, J. A.; Martinez, J. Syntheses and biological activities of bombesin analogues modified in the C-terminal dipeptide part. Eur. J. Med. Chem. 1997, 32, 767-780.
27. Kornreich, W. D.; Galyean, R.; Hernandez, J.-F.; Craig, A. G.; Donaldson, C. J.; Yamamoto, G.; Rivier, C.; Vale, W.; Rivier, J. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. J. Med. Chem. 1992, 35, 1870-1876.
28. Beyermann, M.; Fechner, K.; Furkert, J.; Krause, E.; Bienert, M. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. J. Med. Chem. 1996, 39, 3324-3330.
29. - group on helix stability. Proteins 1989, 5, 1-7.
30. Shoemaker, K. R.; Kim, P. S.; York, E. J.; Stewart, J. M.; Baldwin, R. L. Tests of the helix dipole model for stabilization of α-helices. Nature 1987, 326, 563-567.
31. Vaughan, J.; Donaldson, C.; Bittencourt, J.; Perrin, M. H.; Lewis, K.; Sutton, S.; Chan, R.; Turnbull, A.; Lovejoy, D.; Rivier, C.; Rivier, J.; Sawchenko, P. E.; Vale, W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378, 287-292.
32. Vale, W.; Spiess, J.; Rivier, C.; Brown, M.; Koob, G.; Rivier, J. Chemical and biological characterization of an ovine corticotropin-releasing factor (CRF). Presented at the American Chemical Society Meeting, Symposium on Novel Brain and Gut Hormones, Las Vegas, NV, 1982.
33. Lederis, K.; McMaster, D.; Ichikawa, T.; MacCannell, K. L.; Rivier, J.; Rivier, C.; Vale, W.; Fryer, J.; Kobayashi, Y. Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. Can. J. Biochem. 1983, 61, 602-614.
34. Felix, A. M.; Wang, C.-T.; Heimer, E. P.; Fournier, A. Applications of BOP reagent in solid-phase synthesis. II. Solid-phase side-chain to side-chain cyclizations using BOP reagent. Int. J. Pept. Protein Res. 1988, 31, 231-238.
35. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.